Sign in
4

Changes in Ownership

Protagonist Therapeutics, Inc Filed Acc 0001209191-17-050652

Chief Scientific Officer sold 3,500 shares at $15.00 ($52,500)

  • Chief Scientific Officer acquired 3,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Liu David Y · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2017-08-28 Exercise or conversion : show line 1 in the form +3,500 $4.21 $14,735 5,500 D
2017-08-28 Sale : show line 2 in the form −3,500 $15.00 $52,500 2,000 D
Open-market sales · 3,500 sh · avg $15.00 · $52,500

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2017-08-28 Exercise or conversion : show line 3 in the form Employee Stock Option (right to buy) −3,500 42,331 D
Loading xslF345X03/doc4.xml…